Pure red cell aplasia after a major ABO-mismatched bone marrow transplant for chronic myeloid leukaemia: response to re-introduction of cyclosporin

Hayden, P. J.; Gardiner, N.; Molloy, K.; Ryan, J.; Lawler, M.; McCann, S. R.
February 2004
Bone Marrow Transplantation;Feb2004, Vol. 33 Issue 4, p459
Academic Journal
Presents a study that examined pure red cell aplasia (PRCA) following a major ABO-incompatible bone marrow transplant for chronic myeloid leukemia. Immunohematological complications of bone marrow transplantation in the setting of incompatibility between donor ABO antigens and the recipient immune system; Initial management of delayed erythropoiesis; Role of cyclosporin in the resolution of PRCA.


Related Articles

  • Pure red cell aplasia with the onset of graft versus host disease. Grigg, A. P.; Juneja, S. K. // Bone Marrow Transplantation;Dec2003, Vol. 32 Issue 11, p1099 

    Summary:Pure red cell aplasia (PRCA) occurred in the fourth month after an ABO-compatible nonmyeloablative allograft coincident with the cessation of immunosuppression and the onset of limited chronic GVHD. No secondary causes could be identified. Erythropoiesis was restored promptly and durably...

  • A case of pure red cell aplasia complicated by Evans syndrome. Toyokawa, Yasuhiko; Kingetsu, Isamu; Yauda, Chiho; Yasuda, Jun; Yoshida, Ken; Kurosaka, Daitaro; Yamada, Akio // Modern Rheumatology (Springer Science & Business Media B.V.);Aug2007, Vol. 17 Issue 4, p333 

    A 33-year-old woman complaining of severe anemia was admitted to our hospital for polyclonal hyperglobulinemia. She was diagnosed with pure red cell aplasia (PRCA) associated with Evans syndrome. Initially, the presence of human parvovirus B19 (HPV B19) IgM appeared to indicate that the cause of...

  • Tuberculosis among allogeneic bone marrow transplant recipients in India. George, B; Mathews, V; Srivastava, V; Srivastava, A; Chandy, M // Bone Marrow Transplantation;5/1/2001, Vol. 27 Issue 9, p973 

    Allogeneic bone marrow transplant recipients have severe impairment of cell-mediated immunity and hence a higher incidence of mycobacterial infections might be expected in regions where tuberculosis is common. We reviewed the case records of 217 patients who underwent allogeneic bone marrow...

  • Bone marrow transplantation in Shwachman-Diamond syndrome: report of two cases and review of the literature. Okcu, F.; Roberts, W.M.; Chan, K.W. // Bone Marrow Transplantation;4/15/98, Vol. 21 Issue 8, p849 

    Patients with Shwachman-Diamond syndrome (SDS) have an increased frequency of myelodysplasia and leukemic transformation. We described two patients who received allogeneic stem cell transplantation and developed multiple complications, including seizure, hyperglycemia and renal tubular acidosis....

  • Infectious complications within the first year after nonmyeloablative allogeneic peripheral blood stem cell transplantation. Mossad, S B; Avery, R K; Longworth, D L; Kuczkowski, E M; McBee, M; Pohlman, B L; Sobecks, R M; Kalaycio, M E; Andresen, S W; Macklis, R M; Bolwell, B J // Bone Marrow Transplantation;9/1/2001, Vol. 28 Issue 5, p491 

    Nonmyeloablative peripheral blood stem cell transplantation (PBSCT) is a novel therapeutic strategy for patients with malignant and non-malignant hematologic diseases. Infectious complications of this procedure have not been previously well described. Data on 12 patients transplanted at a...

  • The association of pure red cell aplasia with the antiphospholipid syndrome. Walton, T.; Karim, Y.; Wright, D.; Khamashta, M.; Hughes, G. // Lupus;Dec2001, Vol. 10 Issue 12, p899 

    Presents the case of a patient diagnosed with pure red cell aplasia (PCRA). Medical history of the patient; Results of physical and laboratory examinations; Discussion on PCRA.

  • Pure red cell aplasia due to follow-on epoetin. Keithi-Reddy, Sai Ram; Kandasamy, Sadayandi; Singh, Ajay K // Kidney International;Dec2008, Vol. 74 Issue 12, p1617 

    The article focuses on the case of a 57 year old man with end stage renal disease and interstitial nephritis who underwent a kidney transplant and developed pure red cell aplasia as a result of treatment with epoetin. A discussion of the definition of pure red cell aplasia and its correct...

  • A kidney transplant patient with pure red cell aplasia: first things first! Deeren, Dries // Annals of Hematology;Aug2011, Vol. 90 Issue 8, p991 

    A letter to the editor is presented regarding the case of a 53-year-old kidney transplant patient who had allopurinol-induced pure red cell aplasia (PRCA).

  • Treatment of refractory chronic GVHD with rituximab: a GITMO study. Zaja, F.; Bacigalupo, A.; Patriarca, F.; Stanzani, M.; Van Lint, M. T.; Filì, C.; Scimè, R.; Milone, G.; Falda, M.; Vener, C.; Laszlo, D.; Alessandrino, P. E.; Narni, F.; Sica, S.; Olivieri, A.; Sperotto, A.; Bosi, A.; Bonifazi, F.; Fanin, R. // Bone Marrow Transplantation;Aug2007, Vol. 40 Issue 3, p273 

    The anti-CD20 chimaeric monoclonal antibody Rituximab has recently been shown to induce significant clinical response in a proportion of patients with refractory chronic graft-versus-host disease (cGVHD). We now report 38 patients, median age 48 years (22–61), receiving Rituximab for...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics